{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443860727
| IUPAC_name = 1,1-Dioxo-6-(trifluoromethyl)-3,4-dihydro-2''H''-1,2,4-benzothiadiazine-7-sulfonamide
| image = Hydroflumethiazide.svg
<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|CONS|hydroflumethiazide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| IUPHAR_ligand = 7197
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 135-09-1
| ATC_prefix = C03
| ATC_suffix = AA02
| PubChem = 3647
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00774
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3521
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 501CFL162R
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00654
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1763
<!--Chemical data-->
| C=8 | H=8 | F=3 | N=3 | O=4 | S=2
| molecular_weight = 331.29 g/mol
| smiles = FC(F)(F)c2c(cc1c(NCNS1(=O)=O)c2)S(=O)(=O)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DMDGGSIALPNSEE-UHFFFAOYSA-N
}}

'''Hydroflumethiazide''' (or '''Saluron''') is a [[diuretic]].
== Synthesis ==
[[File:Hydroflumethiazide synthesis.svg|thumb|center|700px|Hydroflumethiazide synthesis:<ref>{{Cite journal | doi = 10.1021/ja01527a015| title = Synthesis of Trifluoromethylated Compounds Possessing Diuretic Activity1| journal = Journal of the American Chemical Society| volume = 81| issue = 18| pages = 4807| year = 1959| last1 = Holdrege | first1 = C. T. | last2 = Babel | first2 = R. B. | last3 = Cheney | first3 = L. C. }}</ref><ref>{{Cite journal | doi = 10.1021/ja01490a028| title = Synthesis of Potential Diuretic Agents. I. Derivatives of 7-Sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-Dioxide| journal = Journal of the American Chemical Society| volume = 82| issue = 5| pages = 1132| year = 1960| last1 = Close | first1 = W. J.| last2 = Swett | first2 = L. R. | last3 = Brady | first3 = L. E. | last4 = Short | first4 = J. H. | last5 = Vernsten | first5 = M. }}</ref><ref>{{Cite journal | doi = 10.1021/jo01076a028| title = Diuretics: 1,2,4-Benzothiadiazine-1,1-dioxides| journal = The Journal of Organic Chemistry| volume = 25| issue = 6| pages = 970| year = 1960| last1 = Novello | first1 = F. C. | last2 = Bell | first2 = S. C. | last3 = Abrams | first3 = E. L. A. | last4 = Ziegler | first4 = C. | last5 = Sprague | first5 = J. M. }}</ref> Numerous patents, e.g., Lund et al., {{US patent|3254076}} (1966 to [[LEO Pharma|LÃ¶vens Kemiske Fabrik]]).]]
== See also ==
*[[Bendroflumethiazide]]

== References ==
{{Reflist|2}}

{{Symporter inhibitors}}
{{Diuretics}}

[[Category:Diuretics]]
[[Category:Sulfonamides]]
[[Category:Benzothiadiazines]]
[[Category:Trifluoromethyl compounds]]
[[Category:Carbonic anhydrase inhibitors]]


{{cardiovascular-drug-stub}}